Last C$0.28 CAD
Change Today +0.005 / 1.82%
Volume 120.9K
LMD On Other Exchanges
Symbol
Exchange
Venture
OTC US
Frankfurt
As of 11:13 AM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

led medical diagnostics inc (LMD) Snapshot

Open
C$0.29
Previous Close
C$0.28
Day High
C$0.31
Day Low
C$0.28
52 Week High
04/7/14 - C$0.57
52 Week Low
12/17/14 - C$0.19
Market Cap
27.8M
Average Volume 10 Days
87.3K
EPS TTM
C$-0.06
Shares Outstanding
99.2M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for LED MEDICAL DIAGNOSTICS INC (LMD)

Related News

No related news articles were found.

led medical diagnostics inc (LMD) Related Businessweek News

No Related Businessweek News Found

led medical diagnostics inc (LMD) Details

LED Medical Diagnostics Inc. is engaged in the development and commercialization of medical devices for the detection and treatment of disease in human tissues primarily in North America. It provides Velscope Vx, an enhanced oral assessment system to screen for oral mucosal tissue anomalies, including early stage oral cancer and pre-cancer. LED Medical Diagnostics, Inc. has an agreement with BC Cancer Agency to create and commercialize a progression-risk assessment test for oral cancer. The company was founded in 2003 and is headquartered in Burnaby, Canada.

40 Employees
Last Reported Date: 11/28/14
Founded in 2003

led medical diagnostics inc (LMD) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $50.3K
Director and President of Led Dental Ltd
Total Annual Compensation: $55.0K
Director of Finance
Total Annual Compensation: $46.5K
Compensation as of Fiscal Year 2013.

led medical diagnostics inc (LMD) Key Developments

LED Medical Diagnostics, Inc. Announces Preliminary Sales Results for the Fiscal Year Ended December 31, 2014; Provides Revenue Guidance for the Year Ending December 31, 2015

LED Medical Diagnostics Inc. announced preliminary sales results for the fiscal year ended December 31, 2014. The company announced preliminary sales and revenue numbers for the fiscal year ended December 31, 2014 in $9.7 million and $8.5 million, respectively. The company experienced customer orders totaling approximately $9.7 million during fiscal 2014 but was not able to install all sales orders prior to year end resulting in approximately $1.2 million of backlog anticipated to be delivered and recognized as revenue in early fiscal 2015. The company is providing guidance for the full fiscal year ending December 31, 2015. The company expects revenue to be in the range of $15 Million to $16 Million.

LED Medical Diagnostics, Inc. Announces Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014; Provides Revenue Guidance for the Full Fiscal Year Ending December 31, 2014

LED Medical Diagnostics, Inc. announced consolidated earnings results for the third quarter and nine months ended September 30, 2014. The company reported revenue of $1,628,643 for the three months ended September 30, 2014 as compared to $911,387 for the three months ended September 30, 2013. Operating loss was $1,977,051 for the three months ended September 30, 2014, as compared to $260,326 for the three months ended September 30, 2013. LBITDA for the three months ended September 30, 2014 was $1,623,618 compared to $139,816 for the three months ended September 30, 2013. Net loss before incomes taxes was $2,693,861 compared to $1,959,544 a year ago. Net loss and comprehensive loss for the period was $2,693,861 or $0.03 per basic and diluted share compared to $1,959,503 or $0.03 per basic and diluted share a year ago. Cash flows used in operating activities were $2,970,787 compared to $739,404 a year ago. Purchase of equipment was $98,635 compared to $1,876 a year ago. The company reported revenue of $4,273,818 for the nine months ended September 30, 2014 as compared to $2,303,860 for the nine months ended September 30, 2013. Operating loss was $4,816,499 for the nine months ended September 30, 2014, as compared to $1,923,094 for the nine months ended September 30, 2013. LBITDA for the nine months ended September 30, 2014 was $4,061,343 compared to $916,082 for the nine months ended September 30, 2013. Net loss before incomes taxes was $5,505,294 compared to $5,490,317 a year ago. Net loss and comprehensive loss for the period was $5,505,294 or $0.07 per basic and diluted share compared to $5,494,416 or $0.12 per basic and diluted share a year ago. Cash flows used in operating activities were $6,253,110 compared to $2,232,895 a year ago. Purchase of equipment was $279,220 compared to $3,067 a year ago. The company is providing revenue guidance for the full fiscal year ending December 31, 2014. The company expects net revenues of $9.0 million - $11.0 million.

LED Medical Diagnostics Inc. Renews its Exclusive International Distribution Agreement (Outside North America) for Three Years with DenMat Holdings LLP

LED Medical Diagnostics Inc. announced that, as of October 1, 2014, it has renewed its exclusive international distribution agreement (outside North America) for three years with DenMat Holdings LLP (DenMat) for its VELscope(R) Vx product line. This agreement requires minimum annual purchases of the VELscope(R) Vx product line by DenMat and is subject to another three-year extension at the mutual agreement of both parties. LED Medical and DenMat have also agreed to assist Mectron SpA, the VELscope(R) Vx distributor in Italy, to establish a VELscope(R) Vx repair center to service customers in Europe. Details of this arrangement will be set out in a separate contract. The company manufactures and markets the VELscope(R) Vx Enhanced Oral Assessment System, the dental adjunctive screening device for defining the extent of a wide range of oral mucosal abnormalities -- from viral, fungal and bacterial infections to cancer and pre-cancer. To-date, more than 25 million VELscope(R) Vx exams have been performed by more than 12,000 dentists in 23 countries.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LMD:CN C$0.28 CAD +0.005

LMD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for LMD.
View Industry Companies
 

Industry Analysis

LMD

Industry Average

Valuation LMD Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 4.2x
Price/Book 6.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 4.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LED MEDICAL DIAGNOSTICS INC, please visit www.velscope.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.